Cite
Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus
MLA
Yusuke Kodama, et al. “Comparison of Bare Metal Stent with Pioglitazone versus Sirolimus-Eluting Stent for Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus.” Cardiovascular Revascularization Medicine : Including Molecular Interventions, vol. 10, no. 1, May 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....afb6571dd0c613f3bcc98abea427759e&authtype=sso&custid=ns315887.
APA
Yusuke Kodama, Meiei Shigemitsu, Takashi Katagiri, Kazuaki Nishio, Noburu Konno, & Youichi Kobayashi. (2008). Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus. Cardiovascular Revascularization Medicine : Including Molecular Interventions, 10(1).
Chicago
Yusuke Kodama, Meiei Shigemitsu, Takashi Katagiri, Kazuaki Nishio, Noburu Konno, and Youichi Kobayashi. 2008. “Comparison of Bare Metal Stent with Pioglitazone versus Sirolimus-Eluting Stent for Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus.” Cardiovascular Revascularization Medicine : Including Molecular Interventions 10 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....afb6571dd0c613f3bcc98abea427759e&authtype=sso&custid=ns315887.